Trial · NCT04311697
Adverse events284
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 284
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | anaemia | Blood and lymphatic system disorders | Aviptadil IV in Escalating Doses + Standard of Care | 8 | 131 | 8 |
| other | anaemia | Blood and lymphatic system disorders | Placebo + Standard of Care | 4 | 65 | 4 |
| other | leukocytosis | Blood and lymphatic system disorders | Aviptadil IV in Escalating Doses + Standard of Care | 8 | 131 | 8 |
| other | leukocytosis | Blood and lymphatic system disorders | Placebo + Standard of Care | 5 | 65 | 5 |
| other | thrombocytopenia | Blood and lymphatic system disorders | Aviptadil IV in Escalating Doses + Standard of Care | 2 | 131 | 2 |
| other | thrombocytopenia | Blood and lymphatic system disorders | Placebo + Standard of Care | 5 | 65 | 5 |
| other | atrial fibrillation | Cardiac disorders | Aviptadil IV in Escalating Doses + Standard of Care | 15 | 131 | 18 |
| other | atrial fibrillation | Cardiac disorders | Placebo + Standard of Care | 3 | 65 | 3 |
| other | bradycardia | Cardiac disorders | Aviptadil IV in Escalating Doses + Standard of Care | 9 | 131 | 9 |
| other | bradycardia | Cardiac disorders | Placebo + Standard of Care | 3 | 65 | 4 |
| other | cardiac arrest | Cardiac disorders | Aviptadil IV in Escalating Doses + Standard of Care | 5 | 131 | 5 |
| other | cardiac arrest | Cardiac disorders | Placebo + Standard of Care | 3 | 65 | 3 |
| other | pulseless electrical activity | Cardiac disorders | Aviptadil IV in Escalating Doses + Standard of Care | 5 | 131 | 5 |
| other | pulseless electrical activity | Cardiac disorders | Placebo + Standard of Care | 2 | 65 | 2 |
| other | sinus arrest | Cardiac disorders | Aviptadil IV in Escalating Doses + Standard of Care | 0 | 131 | 0 |
| other | sinus arrest | Cardiac disorders | Placebo + Standard of Care | 2 | 65 | 2 |
| other | sinus bradycardia | Cardiac disorders | Aviptadil IV in Escalating Doses + Standard of Care | 3 | 131 | 3 |
| other | sinus bradycardia | Cardiac disorders | Placebo + Standard of Care | 2 | 65 | 2 |
| other | sinus tachycardia | Cardiac disorders | Aviptadil IV in Escalating Doses + Standard of Care | 4 | 131 | 5 |
| other | sinus tachycardia | Cardiac disorders | Placebo + Standard of Care | 0 | 65 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04311697/events